|
Diabetes, Vol 45, Issue 2 113-126, Copyright © 1996 by American Diabetes Association
Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit
KD Gerbitz, K Gempel and D Brdiczka
Institute of Clinical Chemistry, Academic Hospital Schwabing, Munchen, Germany.
Physiologically, a postprandial glucose rise induces metabolic signal
sequences that use several steps in common in both the pancreas and
peripheral tissues but result in different events due to specialized tissue
functions. Glucose transport performed by tissue-specific glucose
transporters is, in general, not rate limiting. The next step is
phosphorylation of glucose by cell-specific hexokinases. In the beta-cell,
glucokinase (or hexokinase IV) is activated upon binding to a pore protein
in the outer mitochondrial membrane at contact sites between outer and
inner membranes. The same mechanism applies for hexokinase II in skeletal
muscle and adipose tissue. The activation of hexokinases depends on a
contact site-specific structure of the pore, which is voltage-dependent and
influenced by the electric potential of the inner mitochondrial membrane.
Mitochondria lacking a membrane potential because of defects in the
respiratory chain would thus not be able to increase the
glucose-phosphorylating enzyme activity over basal state. Binding and
activation of hexokinases to mitochondrial contact sites lead to an
acceleration of the formation of both ADP and glucose-6-phosphate (G-6-P).
ADP directly enters the mitochondrion and stimulates mitochondrial
oxidative phosphorylation. G-6-P is an important intermediate of energy
metabolism at the switch position between glycolysis, glycogen synthesis,
and the pentose-phosphate shunt. Initiated by blood glucose elevation,
mitochondrial oxidative phosphorylation is accelerated in a concerted
action coupling glycolysis to mitochondrial metabolism at three different
points: first, through NADH transfer to the respiratory chain complex I via
the malate/aspartate shuttle; second, by providing FADH2 to complex II
through the glycerol-phosphate/dihydroxy-acetone-phosphate cycle; and
third, by the action of hexo(gluco)kinases providing ADP for complex V, the
ATP synthetase. As cytosolic and mitochondrial isozymes of creatine kinase
(CK) are observed in insulinoma cells, the phosphocreatine (CrP) shuttle,
working in brain and muscle, may also be involved in signaling
glucose-induced insulin secretion in beta-cells. An interplay between the
plasma membrane-bound CK and the mitochondrial CK could provide a mechanism
to increase ATP locally at the KATP channels, coordinated to the activity
of mitochondrial CrP production. Closure of the KATP channels by ATP would
lead to an increase of cytosolic and, even more, mitochondrial calcium and
finally to insulin secretion. Thus in beta-cells, glucose, via bound
glucokinase, stimulates mitochondrial CrP synthesis. The same signaling
sequence is used in the opposite direction in muscle during exercise when
high ATP turnover increases the creatine level that stimulates
mitochondrial ATP synthesis and glucose phosphorylation via hexokinase.
Furthermore, this cytosolic/mitochondrial cross-talk is also involved in
activation of muscle glycogen synthesis by glucose. The activity of
mitochondrially bound hexokinase provides G-6-P and stimulates UTP
production through mitochondrial nucleoside diphosphate kinase.
Pathophysiologically, there are at least two genetically different forms of
diabetes linked to energy metabolism: the first example is one form of
maturity-onset diabetes of the young (MODY2), an autosomal dominant
disorder caused by point mutations of the glucokinase gene; the second
example is several forms of mitochondrial diabetes caused by point and
length mutations of the mitochondrial DNA (mtDNA) that encodes several
subunits of the respiratory chain complexes. Because the mtDNA is
vulnerable and accumulates point and length mutations during aging, it is
likely to contribute to the manifestation of some forms of NIDDM.(ABSTRACT
TRUNCATED)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. D. Berdanier
Linking mitochondrial function to diabetes mellitus: an animal's tale
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C830 - C836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Southworth, K. A. B. Davey, A. Warley, and P. B. Garlick
A reevaluation of the roles of hexokinase I and II in the heart
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H378 - H386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai
Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
J Appl Physiol,
December 1, 2006;
101(6):
1685 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bertoldo, R. R. Pencek, K. Azuma, J. C. Price, C. Kelley, C. Cobelli, and D. E. Kelley
Interactions Between Delivery, Transport, and Phosphorylation of Glucose in Governing Uptake Into Human Skeletal Muscle
Diabetes,
November 1, 2006;
55(11):
3028 - 3037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kumar, R. Verma, and G. P. S. Raghava
Prediction of Mitochondrial Proteins Using Support Vector Machine and Hidden Markov Model
J. Biol. Chem.,
March 3, 2006;
281(9):
5357 - 5363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Y. Park, G. H. Choi, H. I. Choi, J. Ryu, C. Y. Jung, and W. Lee
Depletion of Mitochondrial DNA Causes Impaired Glucose Utilization and Insulin Resistance in L6 GLUT4myc Myocytes
J. Biol. Chem.,
March 18, 2005;
280(11):
9855 - 9864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hittel, W. E. Kraus, C. J. Tanner, J. A. Houmard, and E. P. Hoffman
Exercise training increases electron and substrate shuttling proteins in muscle of overweight men and women with the metabolic syndrome
J Appl Physiol,
January 1, 2005;
98(1):
168 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, J. H. Bae, S.-Y. Kim, H.-Y. Lee, B.-C. Jang, I.-K. Lee, C.-H. Cho, J.-G. Lim, S.-I. Suh, T.-K. Kwon, et al.
Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondrial metabolism
Am J Physiol Endocrinol Metab,
November 1, 2004;
287(5):
E1008 - E1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev.,
October 1, 2004;
25(5):
807 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani
Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress
Diabetes,
January 1, 2004;
53(1):
185 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bruce, M. J. Anderson, A. L. Carey, D. G. Newman, A. Bonen, A. D. Kriketos, G. J. Cooney, and J. A. Hawley
Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status
J. Clin. Endocrinol. Metab.,
November 1, 2003;
88(11):
5444 - 5451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Dzeja and A. Terzic
Phosphotransfer networks and cellular energetics
J. Exp. Biol.,
June 15, 2003;
206(12):
2039 - 2047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. I. Moreira, M. S. Santos, A. M. Moreno, R. Seica, and C. R. Oliveira
Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-{beta} Exposure
Diabetes,
June 1, 2003;
52(6):
1449 - 1456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Diabetes,
October 1, 2002;
51(10):
2944 - 2950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T.W. Choo-Kang, S. Lynn, G. A. Taylor, M. E. Daly, S. S. Sihota, T. M. Wardell, P. F. Chinnery, D. M. Turnbull, and M. Walker
Defining the Importance of Mitochondrial Gene Defects in Maternally Inherited Diabetes by Sequencing the Entire Mitochondrial Genome
Diabetes,
July 1, 2002;
51(7):
2317 - 2320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohkubo, A. Yamano, M. Nagashima, Y. Mori, K. Anzai, Y. Akehi, R. Nomiyama, T. Asano, A. Urae, and J. Ono
Mitochondrial Gene Mutations in the tRNALeu(UUR) Region and Diabetes: Prevalence and Clinical Phenotypes in Japan
Clin. Chem.,
September 1, 2001;
47(9):
1641 - 1648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Chan, D. De Leo, J. W. Joseph, T. S. McQuaid, X. F. Ha, F. Xu, R. G. Tsushima, P. S. Pennefather, A. M. F. Salapatek, and M. B. Wheeler
Increased Uncoupling Protein-2 Levels in {beta}-cells Are Associated With Impaired Glucose-Stimulated Insulin Secretion: Mechanism of Action
Diabetes,
June 1, 2001;
50(6):
1302 - 1310.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-S. Park, K.-J. Nam, J.-W. Kim, Y.-B. Lee, C.-Y. Han, J.-K. Jeong, H.-K. Lee, and Y. K. Pak
Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells
Am J Physiol Endocrinol Metab,
June 1, 2001;
280(6):
E1007 - E1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Novel-Chate, V. Rey, R. Chiolero, P. Schneiter, X. Leverve, E. Jequier, and L. Tappy
Role of Na+-K+-ATPase in insulin-induced lactate release by skeletal muscle
Am J Physiol Endocrinol Metab,
February 1, 2001;
280(2):
E296 - E300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O.'t Eijnde, B. Ursø, E.A. Richter, P.L. Greenhaff, and P. Hespel
Effect of Oral Creatine Supplementation on Human Muscle GLUT4 Protein Content After Immobilization
Diabetes,
January 1, 2001;
50(1):
18 - 23.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev,
July 1, 2000;
80(3):
1107 - 1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F Chinnery, N. Howell, R. M Andrews, and D. M Turnbull
Clinical mitochondrial genetics
J. Med. Genet.,
June 1, 1999;
36(6):
425 - 436.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev.,
April 1, 1999;
20(2):
101 - 135.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. Gerich
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
Endocr. Rev.,
August 1, 1998;
19(4):
491 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Murray-McIntosh, B. J. Scrimshaw, P. J. Hatfield, and D. Penny
Testing migration patterns and estimating founding population size in Polynesia by using human mtDNA sequences
PNAS,
July 21, 1998;
95(15):
9047 - 9052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Trueblood and R. Ramasamy
Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts
Am J Physiol Heart Circ Physiol,
July 1, 1998;
275(1):
H75 - H83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Dzeja and A. Terzic
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels
FASEB J,
May 1, 1998;
12(7):
523 - 529.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. L. Rosenbloom, D. V. House, and W. E. Winter
Non-Insulin Dependent Diabetes Mellitus (NIDDM) in Minority Youth: Research Priorities and Needs
Clinical Pediatrics,
February 1, 1998;
37(2):
143 - 152.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wada and Y. S. Kanwar
Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney
PNAS,
January 6, 1998;
95(1):
144 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Allen and C. W. White
Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP
Am J Physiol Lung Cell Mol Physiol,
January 1, 1998;
274(1):
L159 - L164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev.,
December 1, 1997;
18(6):
774 - 800.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. L. Smith, X.-Y. Hua, D. L. Marsden, D. Liu, N. G. Kennaway, K.-Y. Ngo, and R. H. Haas
Diabetes and Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): Radiolabeled Polymerase Chain Reaction Is Necessary for Accurate Detection of Low Percentages of Mutation
J. Clin. Endocrinol. Metab.,
September 1, 1997;
82(9):
2826 - 2831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Simoneau and D. E. Kelley
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM
J Appl Physiol,
July 1, 1997;
83(1):
166 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|